Cytomel

   
Google
 
Web NewDrugInformation.com

Cytomel


Drug - Cytomel
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Liothyronine Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 0.025MG BASE
The potency of the active ingredient(s), Liothyronine Sodium. May repeat for multiple part products.

Applicant - KING PHARMS
The firm name holding legal responsibility for Cytomel. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 010379
The FDA assigned number to Cytomel. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Cytomel. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Cytomel was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Cytomel. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Cytomel is in. Format is RX, OTC, DISCN.

Applicant Full Name - King Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Cytomel.

Cytomel